Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: A prospective study

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 1, 2006, Pages

  Maurer, Kirk J ^a   Rogers, Arlin B ^a   Ge, Zhongming ^a   Wiese, Ashley J ^a   Carey, Martin C ^b,c   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bile; Cholesterol crystals; Gastritis; Lithogenic; Mucin

Indexed keywords

CHOLESTEROL; CHOLIC ACID; TRIACYLGLYCEROL; BACTERIAL DNA;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CHOLESTEROL STONE; CONTROLLED STUDY; DIET; DISEASE EXACERBATION; DISEASE SEVERITY; FORESTOMACH; GALLBLADDER; GALLSTONE FORMATION; GASTRITIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; MALE; MICROSCOPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN SIZE; PHENOTYPE; PRIORITY JOURNAL; RAT STRAIN; STONE FORMATION; ANIMAL; BILE; GALLSTONE; LIVER; METABOLISM; MICROBIOLOGY; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH;

ANIMALS; BILE; CHOLESTEROL; DIET; DNA, BACTERIAL; GALLBLADDER; GALLSTONES; HELICOBACTER PYLORI; LIVER; MALE; MICE; MICE, INBRED STRAINS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STOMACH;

EID: 33644805375     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00272.2005     Document Type: Article

References (56)

1. Albertini R, Moratti R, and De Luca G. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr Mol Med 2: 579-592, 2002.
2. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, and Trust TJ. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397: 176-180, 1999.
3. Ananieva O, Nilsson I, Vorobjova T, Uibo R, and Wadström T. Immune responses to bile-tolerant helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors. Clin Diagn Lab Immunol 9: 1160-1164, 2002.
4. Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, and Megraud F. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89: 1431-1439, 2000.
5. Bird RP. Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon. Cancer Lett 88: 201-209, 1995.
6. Bouchard G, Nelson HM, Lammert F, Rowe LB, Carey MC, and Paigen B. High-resolution maps of the murine chromosome 2 region containing the cholesterol gallstone locus, Lith1. Mamm Genome 10: 1070-1074, 1999.
7. Bulajic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, Stimec B, Lehn N, Lowenfels AB, and Lohr M. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 95: 1946-1953, 2002.
8. Carey MC. Pathogenesis of gallstones. Am J Surg 165: 410-419, 1993.
9. Carey MC. Pathogenesis of gallstones. Recenti Prog Med 83: 379-391, 1992.
10. Carey MC, Kwon RS, Maurer KJ, and Fox JG. State of the art gallstone research in the post-genomic era. In: Gallstones: Pathogenesis and Treatment, edited by Adler G, Blum HE, Fuchs M, and Strange EF. Dordrecht, The Netherlands: Kluwer, 2004, p. 207-227.
11. Carey MC and Paigen B. Epidemiology of the American Indians' burden and its likely genetic origins. Hepatology 36: 781-791, 2002.
12. Doster AR. Porcine gastric ulcer. Vet Clin North Am Food Anim Pract 16: 163-174, 2000.
13. Fallone CA, Tran S, Semret M, Discepola F, Behr M, and Barkun AN. Helicobacter DNA in bile: correlation with hepato-biliary diseases. Aliment Pharmacol Ther 17: 453-458, 2003.
14. Farshad S, Alborzi A, Malek Hosseini SA, Oboodi B, Rasouli M, Japoni A, and Nasiri J. Identification of Helicobacter pylori DNA in Iranian patients with gallstones. Epidemiol Infect 132: 1185-1189, 2004.
15. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, and Roa I. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114: 755-763, 1998.
16. Fox JG, MacGregor JA, Shen Z, Li X, Lewis R, and Dangler CA. Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay. J Clin Microbiol 36: 1382-1387, 1998.
17. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, and Wang TC. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 63: 942-950, 2003.
18. Fox JG, Rogers AB, Whary MT, Ge Z, Taylor NS, Xu S, Horwitz BH, and Erdman SE. Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 72: 1116-1125, 2004.
19. Fox JG, Shen Z, Xu S, Feng Y, Dangler CA, Dewhirst FE, Paster BJ, and Cullen JM. Helicobacter marmotae sp. nov isolated from livers of woodchucks and intestines of cats. J Clin Microbiol 40: 2513-2519, 2002.
20. Ge Z, White DA, Whary MT, and Fox JG. Fluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticus. J Clin Microbiol 39: 2598-2602, 2001.
21. Gregg JA, De Girolami P, and Carr-Locke DL. Effects of sphincteroplasty and endoscopic sphincterotomy on the bacteriologic characteristics of the common bile duct. Am J Surg 149: 668-671, 1985.
22. Hanninen ML. Sensitivity of Helicobacter pylori to different bile salts. Eur J Clin Microbiol Infect Dis 10: 515-518, 1991.
23. Heinle H, Brehme U, Friedemann G, Frey JC, Wolf AT, Kelber O, Weiser D, Schmahl FW, Lang F, and Schneider W. Intimal plaque development and oxidative stress in cholesterol-induced atherosclerosis in New Zealand rabbits. Acta Physiol Scand 176: 101-107, 2002.
24. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, and Nakayama J. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305: 1003-1006, 2004.
25. Khanuja B, Cheah YC, Hunt M, Nishina PM, Wang DQH, Chen HW, Billheimer JT, Carey MC, and Paigen B. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 92: 7729-7733, 1995.
26. Krakowka S, Eaton KA, Rings DM, and Argenzio RA. Production of gastroesophageal erosions and ulcers (GEU) in gnotobiotic swine monoinfected with fermentative commensal bacteria and fed high-carbohydrate diet. Vet Pathol 35: 274-282, 1998.
27. Lammert F, Wang DQH, Paigen B, and Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes. J Lipid Res 40: 2080-2090, 1999.
28. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, and Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112: 1386-1397, 1997.
29. Leininger JR, Jokinen MP, Dangler CA, and Whiteley LO. Oral Cavity, esophagus, and stomach. In: Pathology of the Mouse (1st ed.), edited by Maronpot RR. Vienna, IL: Cache River, 1999, p. 29-48.
30. Leong RW and Sung JJ. Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16: 1037-1045, 2002.
31. Lopez-Carrillo L, Lopez-Cervantes M, Ward MH, Bravo-Alvarado J, and Ramirez-Espitia A. Nutrient intake and gastric cancer in Mexico. Int J Cancer 83: 601-605, 1999.
32. Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, Kamiya S, Naito Z, and Fox JG. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 93: 842-847, 2002.
33. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, Carey MC, and Fox JG. Identification of cholelithogenic enterohepatic Helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 128: 1023-1033, 2005.
34. Mayne ST and Navarro SA. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr 132: 3467S-3470S, 2002.
35. Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West AB, Rotterdam H, Blot WJ, and Fraumeni JF Jr. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 10: 1055-1062, 2001.
36. Meagher E and Rader DJ. Antioxidant therapy and atherosclerosis: animal and human studies. Trends Cardiovasc Med 11: 162-165, 2001.
37. Munro R and Sorrell Biliary sepsis TC. Reviewing treatment options. Drugs 31: 449-454, 1986.
38. Murata H, Tsuji S, Tsujii M, Fu HY, Tanimura H, Tsujimoto M, Matsuura N, Kawano S, and Hori M. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther 20, Suppl 1: 90-94, 2004.
39. Myung SJ, Kim MH, Shim KN, Kim YS, Kim EO, Kim HJ, Park ET, Yoo KS, Lim BC, Seo DW, Lee SK, Min YI, and Kim JY. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig Dis Sci 45: 1405-1412, 2000.
40. O'Rourke JL, Solnick JV, Neilan BA, Seidel K, Hayter R, Hansen LM, and Lee A. Description of "Candidatus Helicobacter heilmannii" based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol 54: 2203-2211, 2004.
41. Paigen B and Carey MC. Gallstones. In: The Genetic Basis of Common Diseases (2nd ed.), edited by King RA, Rotter JI, and Motulsky AG. New York: Oxford University Press, 2002, p. 1096.
42. Paigen B, Schork NJ, Svenson KL, Cheah YC, Mu JL, Lammert F, Wang DQ, Bouchard G, and Carey MC. Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol Genomics 4: 59-65, 2000.
43. Queiroz DM, Rocha GA, Mendes EN, De Moura SB, De Oliveira AM, and Miranda D. Association between Helicobacter and gastric ulcer disease of the pars esophagea in swine. Gastroenterology 111: 19-27, 1996.
44. Queiroz DM and Santos A. Isolation of a Helicobacter strain from the human liver. Gastroenterology 121: 1023-1024, 2001.
45. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, and Sandler RS. Digestive and liver diseases statistics, 2004. Gastroenterology 126: 1448-1453, 2004.
46. Shaked G, Ovnat A, Eyal A, Fraser D, Klain J, Peiser J, and Charuzi I. Acute acalculous cholecystitis- experimental and clinical observations. Isr J Med Sci 24: 401-404, 1988.
47. Silva CP, Pereira-Lima JC, Oliveira AG, Guerra JB, Marques DL, Sarmanho L, Cabral MM, and Queiroz DM. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol 41: 5615-5618, 2003.
48. Sutherland LA and Bird RP. The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. Cancer Lett 76: 101-107, 1994.
49. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, and Venter JC. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547, 1997.
50. Wadström T and Ljungh AA. Chronic Helicobacter infection of the human liver and bile are common and may trigger autoimmune disease. Curr Gastroenterol Rep 4: 349-350, 2002.
51. Wang DQH, Lammert F, Cohen DE, Paigen B, and Carey MC. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis. Am J Physiol Gastrointest Liver Physiol 276: G751-G760, 1999.
52. Wang DQH, Paigen B, and Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 38: 1395-1411, 1997.
53. Whary MT, Cline J, King A, Ge Z, Shen Z, Sheppard B, and Fox JG. Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Comp Med 51: 413-417, 2001.
54. Wittenburg H, Lyons MA, Paigen B, and Carey MC. Mapping cholesterol gallstone susceptibility (Lith) genes in inbred mice. Dig Liver Dis 35, Suppl 3: S2-S7, 2003.
55. Worku ML, Karim QN, Spencer J, and Sidebotham RL. Chemotactic response of Helicobacter pylori to human plasma and bile. J Med Microbiol 53: 807-811, 2004.
56. Yoshida Y, Tatematsu M, Takaba K, Shichino Y, and Ito N. Effects of various bile acids and their sodium salts on development of pepsinogen-altered pyloric glands in rats. Teratog Carcinog Mutagen 12: 179-186, 1992.